<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03254121</url>
  </required_header>
  <id_info>
    <org_study_id>SAleman</org_study_id>
    <nct_id>NCT03254121</nct_id>
  </id_info>
  <brief_title>Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response</brief_title>
  <acronym>HEPCASUS</acronym>
  <official_title>Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this international collaboration study, the research group will analyze somatic mutations
      of hepatocellular carcinoma (HCC) developed after sustained virological response (SVR) in
      patients treated with hepatitis C (HCV) therapy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Method Paired liver tissue samples will be collected from the tumour sections and also from
      the adjacent non-tumour tissues, for comparison in each individual. The tissues have been
      collected as part of routine clinical work/other studies, by liver biopsies or at liver
      resection/liver transplantation. Data regarding the patient characteristic will be collected.
      Whole genome sequencing analyses are planned to be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterisation of genomic mutations of HCC, developed in HCV patients with SVR</measure>
    <time_frame>5 years</time_frame>
    <description>Genetic characteristics of HCCs will be compared to non-HCC tissue</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <condition>Hepatitis C</condition>
  <arm_group>
    <arm_group_label>Patients with SVR and developed HCC</arm_group_label>
    <description>HCV patients with SVR and developed HCC plus available tissue from HCC</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Liver tissue from HCC and adjacent non-HCC
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Please see eligibility criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with sustained virological response (SVR) after interferon (IFN)-containing
             or IFN-free treatment, and developed hepatocellular carcinoma (HCC)

          -  Available liver biopsies from hepatocellular carcinoma and non-HCC tissue

        Exclusion Criteria:

          -  Co-infection with chronic hepatitis B (HBsAg positive) or HIV infection.

          -  Liver transplantation prior to treatment-start, leading to SVR.

          -  Patients with diagnosed HCC prior to treatment-start, leading to SVR.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Bolinder, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Soo Aleman, Assoc prof</last_name>
    <phone>+46 8 58 58 0000</phone>
    <email>soo.aleman@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Karolinska Institutet</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soo Aleman, Assoc prof</last_name>
      <phone>+46 8 58 58 0000</phone>
      <email>soo.aleman@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2017</study_first_submitted>
  <study_first_submitted_qc>August 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2017</study_first_posted>
  <last_update_submitted>September 2, 2017</last_update_submitted>
  <last_update_submitted_qc>September 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Soo Aleman</investigator_full_name>
    <investigator_title>MD, PhD, Assoc prof</investigator_title>
  </responsible_party>
  <keyword>Sustained virological response</keyword>
  <keyword>Whole genome sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual IPD will not be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

